Milosevich Gregory M Form 3 Filed 2025-07-01

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:		3235-0104
Expires:	02/28/2011
Estimated average burden
hours per response		0.5

1. Name and Address of Reporting Person ^*

Milosevich Gregory M

2. Date of Event Requiring Statement (Month/Day/Year)

07/01/2025

3. Issuer Name and Ticker or Trading Symbol

DANAHER CORP /DE/ [DHR]

(Last)

(First)

(Middle)

2200 PENNSYLVANIA AVE NW, SUITE 800W

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Executive Vice President

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

WASHINGTON, DC 20037

(City)

(State)

(Zip)

6. Individual or Joint/Group Filing

(Check applicable line)

__X__ Form Filed by One Reporting Person
_____ Form Filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4,455	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Danaher Deferred Compensation Programs - Danaher Stock Fund⁽¹⁾	⁽²⁾	⁽²⁾	Common Stock	4,382.374	$ 0 ⁽³⁾	D
Employee stock option (right to buy)	02/24/2016⁽⁴⁾	02/24/2026	Common Stock	1,320	$58.59	D
Employee stock option (right to buy)	02/24/2017⁽⁴⁾	02/24/2027	Common Stock	2,405	$76.47	D
Employee stock option (right to buy)	02/24/2017⁽⁴⁾	02/24/2027	Common Stock	482	$76.47	D
Employee stock option (right to buy)	02/24/2018⁽⁴⁾	02/24/2028	Common Stock	3,918	$88.24	D
Employee stock option (right to buy)	02/24/2019⁽⁴⁾	02/24/2029	Common Stock	5,629	$100.81	D
Employee stock option (right to buy)	07/15/2019⁽⁴⁾	07/15/2029	Common Stock	5,097	$125.35	D
Employee stock option (right to buy)	02/24/2020⁽⁴⁾	02/24/2030	Common Stock	5,572	$139.3	D
Employee stock option (right to buy)	02/24/2021⁽⁴⁾	02/24/2031	Common Stock	4,458	$198.09	D
Employee stock option (right to buy)	11/15/2021⁽⁴⁾	11/15/2031	Common Stock	2,348	$266.2	D
Employee stock option (right to buy)	02/24/2022⁽⁵⁾	02/24/2032	Common Stock	5,034	$241.22	D
Employee stock option (right to buy)	02/24/2023⁽⁵⁾	02/24/2033	Common Stock	7,328	$221.29	D
Employee stock option (right to buy)	02/24/2023⁽⁵⁾	02/24/2033	Common Stock	6,107	$221.29	D
Employee stock option (right to buy)	03/01/2024⁽⁵⁾	03/01/2034	Common Stock	3,490	$255.87	D
Employee stock option (right to buy)	03/01/2024⁽⁵⁾	03/01/2034	Common Stock	6,049	$255.87	D
Employee stock option (right to buy)	03/01/2025⁽⁵⁾	03/01/2035	Common Stock	13,753	$207.76	D

Explanation of Responses:

1.	Represents the participant's and/or Company contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited.
2.	The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.
3.	The notional shares convert on a one-for-one basis.
4.	Date shown is grant date. Twenty percent of the options became or become exercisable on each of the first five anniversaries of the grant date.
5.	Date shown is grant date. Twenty-five percent of the options became or become exercisable on each of the first four anniversaries of the grant date.
Remarks: Exhibit List: Exhibit 24 - Power of Attorney

	Signatures
	/s/ James F. O'Reilly, as attorney-in-fact for Gregory M Milosevich	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints James F. O’Reilly and Zohaib Khalid, signing singly, each as the undersigned's true and lawful attorney-in-fact to:

(1) execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Danaher Corporation (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that each foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 7 day of April, 2025.

By: /s/ Greg Milosevich

Name: Greg Milosevich